Home » Business » Manufacturing
Roche invests in contagious disease center
Print Edition
SWISS pharmaceutical giant Roche yesterday said it will invest 136 million Swiss francs (US$140 million) in a new research center in Shanghai to work on discovery and development of infectious diseases.
The new Roche Innovation Center will collaborate with the local scientific community to research, discover and develop infectious diseases.
“We’re sharpening our focus on drug discovery, research and early clinical development to address unmet medical demands in infectious diseases in Asia and globally,” said John Reed, head of Roche Pharma Research and Early Development.
The 14,000-square-meter new research center, located at Shanghai Roche Pharmaceutical Ltd’s current site in Zhangjiang in the Pudong New Area, is set to start operation in 2018.
Stella Xu, site head of Roche Innovation Center Shanghai, said yesterday that innovations made by Chinese scientists at the Shanghai site can be transformed quickly into real medicines to treat patients in China and worldwide.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
